DETECTING DISEASE EARLY FOR TOMORROW’S HEALTH
Hummingbird’s Mission is to harness the power of blood borne miRNAs to “read” the immune system’s response to disease, enhancing the potential for innovative disease screening, symptom-based diagnostics, disease-specific prognostics as well as monitoring of patient-centric therapies. The privately held company is based in Heidelberg, Germany.